Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926653 · ClinicalTrials.gov registry record
Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
A clinical trial of Depression, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT00926653: Completed study of Depression, sponsored by Weill Medical College of Cornell University.
NCT00926653 is a study of Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 76 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926653, a study of Depression, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine differences in activity of the anterior cingulate cortex, a brain area involved in emotion and cognitive regulation, between older adults with and without depression.
Conditions Studied
Interventions
- DRUG Escitalopram
Study Locations (1)
New York
- New York Presbyterian-Weill Cornell Medical College - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-05 |
What the finished NCT00926653 record still lists
NCT00926653 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Escitalopram is the first listed.
NCT00926653 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00926653 about?
NCT00926653 is a clinical study titled "Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression". This study will examine differences in activity of the anterior cingulate cortex, a brain area involved in emotion and cognitive regulation, between older adults with and without depression.
What is the current status of trial NCT00926653?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2005-07. Estimated completion is 2010-05.
What conditions does trial NCT00926653 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00926653?
The interventions under investigation include: Escitalopram (DRUG).
Who is sponsoring clinical trial NCT00926653?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00926653 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00926653's enrollment target sits among peer trials
76 384th of 679 higher than 294 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia